APA

Tanimoto K., Muranski P., Miner S., Fujiwara H., Kajigaya S., Keyvanfar K., Hensel N., Barrett A. J. & Melenhorst J. J. (20140818). Genetically engineered fixed K562 cells: potent "off-the-shelf" antigen-presenting cells for generating virus-specific T cells. : Cytotherapy.

Chicago

Tanimoto Kazushi, Muranski Pawel, Miner Samantha, Fujiwara Hiroshi, Kajigaya Sachiko, Keyvanfar Keyvan, Hensel Nancy, Barrett A John and Melenhorst J Joseph. 20140818. Genetically engineered fixed K562 cells: potent "off-the-shelf" antigen-presenting cells for generating virus-specific T cells. : Cytotherapy.

Harvard

Tanimoto K., Muranski P., Miner S., Fujiwara H., Kajigaya S., Keyvanfar K., Hensel N., Barrett A. J. and Melenhorst J. J. (20140818). Genetically engineered fixed K562 cells: potent "off-the-shelf" antigen-presenting cells for generating virus-specific T cells. : Cytotherapy.

MLA

Tanimoto Kazushi, Muranski Pawel, Miner Samantha, Fujiwara Hiroshi, Kajigaya Sachiko, Keyvanfar Keyvan, Hensel Nancy, Barrett A John and Melenhorst J Joseph. Genetically engineered fixed K562 cells: potent "off-the-shelf" antigen-presenting cells for generating virus-specific T cells. : Cytotherapy. 20140818.